News and Announcements
Novogen CEO interviewed on CommSec
- Published July 04, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
CommSec released an interview today as part of its Executive Series, featuring Executive Director and CEO, Dr James Garner.
KEY TAKEAWAYS:
- Tom Piotrowski talks with Dr Garner about Novogen’s business model and the way it is being used to bring to market the best of available cancer treatments.
- Providing an overview of Novogen’s pipeline.
Dr Garner talked about the next steps for the Company’s lead candidate GDC-0084, a drug to treat Glioblastoma Multiforme. GDC-0084 was licenced from Genentech, and showed great promise in a Phase I clinical trial. A Phase II clinical trial is expected will start later this year.
Company Updates
Everything is now competing for the same dollar
Key takeaways As recently as 2022, Germany and Japan could borrow for 30 years at close to zero. That world is gone, and AI is now bidding for what is left. Over the past fortnight, I listened to founders, operators and allocators describe where their industries are heading. They covered four very different frontiers. Each […]
Australia has not held 90 days of fuel since 2012. The fix may start at a sewage plant.
A decommissioned council treatment site in Bundaberg is being built into a $188.9 million biorefinery. Its managing director is candid that the largest revenue line is not yet contracted. Australia has not met its international 90-day fuel reserve obligation since 2012. Around 90 per cent of the country’s liquid fuel is imported. Andy Whitmore, Managing […]
Forget Startups: Why Magnetic Alliance is Betting on “Boring” Mid-Market Turnarounds
While Australia’s venture capital scene spent years chasing unprofitable tech startups and speculative high-growth plays, Mark Lim was quietly taking a radically different path. The Managing Partner of Magnetic Alliance Capital sees the nation’s richest investment opportunities hiding in plain sight: inside thousands of unglamorous, profitable, but operationally sluggish mid-market businesses. Speaking on Wholesale Investor’s […]
Backed By Leading Investment Groups and Family Offices
